[JNJ]
Mid
Mid
2026-10-26 06:56:54
Johnson & Johnson reports response rate for head, neck cancer treatment
Mid
2026-10-19 21:12:47
J&J’s Tremfya shows maintained fistula remission in Crohn’s trial
Mid
2026-10-14 05:49:10
Johnson & Johnson raises 2026 sales outlook to 6.7%-7.1% while projecting $100.7B midpoint revenue
Mid
2026-10-14 02:23:35
Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ
Mid
2026-10-14 01:09:45
J&J shares down despite guidance raise as MedTech revenues disappoint
1 / 9